I see a potential breakout with a 25% upside after three months of strong consolidation. I'm planning to enter at 2550 with a stop loss at 2475. Target 1 is 3045, and Target 2 is 3375. Let's monitor this closely!
AJANTPHARM
注释
Starting from an entry price of 2550, it has now reached 2815, achieving 10% of the first target of 3045, which is 19%. We are awaiting the remaining 9% to reach the first target.注释
Still in the range to consider it免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。